RIZVII
LIVE

Serial Number

99796590

Owner

Glaxo Group Limited

Attorney

Christopher M. Hanes

Filing Date

Apr 30, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RIZVII Trademark

Serial Number: 99796590

RIZVII is a trademark filed by Glaxo Group Limited on April 30, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Glaxo Group Limited (135 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

April 30, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 24, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 24, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jul 24, 2026 CNSL
ASSIGNED TO EXAMINER
Jul 22, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 30, 2026 MAFR
NEW APPLICATION ENTERED
Apr 30, 2026 NWAP